From drug substance to drug product: Why integration matters in modern pharmaceutical development
As pharmaceutical development becomes more complex, connecting expertise across the development pathway can help teams make better-informed decisions earlier. This Almac Voice explores why integration matters from drug substance through to drug product, including the links between starting materials, API characteristics, formulation, analytical science, manufacturing, packaging and clinical supply. It examines how a more connected approach can help reduce development risk, address bioavailability and manufacturability challenges, and maintain momentum from early development through clinical and commercial progression.
Read the full Almac Voice to discover how an integrated approach can help connect drug substance and drug product development and reduce complexity from molecule to medicine.